Raymond James analyst Robert Dodd raised the firm’s price target on Crescent Capital BDC to $19 from $18 and keeps an Outperform rating on the shares. Crescent Capital’s Q1 results were above consensus estimates, with NAV per share improving 1.2% and solid credit quality, the analyst tells investors in a research note. The firm sees an attractive risk/reward, with a conservatively implemented variable dividend policy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCAP: